This list is an analysis based on recent market events. It's not an investment recommendation.
About
UniPharma Co., Ltd. is a Taiwanese enterprise specializing in the distribution of pharmaceuticals, medical apparatus, and diagnostic kits. Its diagnostic portfolio encompasses various medical disciplines, including oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. The company's offerings feature products such as Adept reduction solution, anesthetic injections (including bain, esmolol HCI, and naloxone), the Elisa DR-70 test for in-vitro tumor detection, and Fomeject antidote injections. Furthermore, UniPharma extends its services to include drug development, research and development, clinical studies, and marketing. Its client base includes major medical centers, regional hospitals, and local clinics. Founded in 1998, UniPharma is headquartered in Taipei, Taiwan.
The current price of 6621.TWO is TWD12.25 TWD — it has decreased by -0.81% in the past 24 hours. Watch Uni Pharma stock price performance more closely on the chart.
What is Uni Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Uni Pharma stocks are traded under the ticker 6621.TWO.
Is Uni Pharma stock price growing?▼
6621.TWO stock has fallen by -1.61% compared to the previous week, the month change is a -0.41% fall, over the last year Uni Pharma has showed a +0.41% increase.
What is Uni Pharma market cap?▼
Today Uni Pharma has the market capitalization of 434.89M
What is Uni Pharma revenue for the last year?▼
Uni Pharma revenue for the last year amounts to 88.44M TWD.
What is Uni Pharma net income for the last year?▼
6621.TWO net income for the last year is -40.54M TWD.
How many employees does Uni Pharma have?▼
As of November 5, 2026, the company has 34 employees.
In which sector is Uni Pharma located?▼
Uni Pharma operates in the Health & Wellness sector.